Skip to main content
. 2019 Sep 10;1:13. doi: 10.3389/fspor.2019.00013

Table 4.

Characteristics of reported acute and overuse injuries [results are presented in numbers (percentage)].

All athletes Male athletes Female athletes
Total Endurance athletes Explosive athletes Total Endurance male athletes Explosive male athletes Total Endurance female athletes Explosive female athletes
Total Acute Overuse Acute Overuse Total Total Acute Overuse Total Acute Overuse Total Total Acute Overuse Total Acute Overuse
TOTAL 117 (100.0) 9 (100.0) 24 (100.0) 38 (100.0) 46 (100.0) 64 (100.0) 25 (100.0) 8 (100.0) 17 (100.0) 39 (100.0) 19 (100.0) 20 (100.0) 53 (100.0) 8 (100.0) 1 (100.0) 7 (100.0) 45 (100.0) 19 (100.0) 26 (100.0)
LOCATION
Head 1 (0.9) 0 (0.0) 0 (0.0) 1 (2.6) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (1.9) 0 (0.0) 0 (0.0) 0 (0.0) 1 (2.2) 1 (5.3) 0 (0.0)
Trunk 15 (12.8) 1 (11.1) 0 (0.0) 8 (21.1) 6 (13.0) 9 (14.1) 0 (0.0) 0 (0.0) 0 (0.0) 9 (23.1) 6 (31.6) 3 (15.0) 6 (11.3) 1 (12.5) 1 (100.0) 0 (0.0) 5 (11.1) 2 (10.5) 3 (11.5)
Upper extremity 9 (7.7) 1 (11.1) 0 (0.0) 3 (7.9) 5 (10.9) 7 (10.9) 1 (4.0) 1 (12.5) 0 (0.0) 6 (15.4) 3 (15.8) 3 (15.0) 2 (3.8) 0 (0.0) 0 (0.0) 0 (0.0) 2 (4.4) 0 (0.0) 2 (7.7)
Pelvic/Hip/Groin 12 (10.3) 1 (11.1) 4 (16.7) 4 (10.5) 3 (6.5) 5 (7.8) 2 (8.0) 1 (12.5) 1 (5.9) 3 (7.7) 2 (10.5) 1 (5.0) 7 (13.2) 3 (37.5) 0 (0.0) 3 (42.9) 4 (8.9) 2 (10.5) 2 (7.7)
Quadriceps 5 (4.3) 0 (0.0) 0 (0.0) 3 (7.9) 2 (4.3) 2 (3.1) 0 (0.0) 0 (0.0) 0 (0.0) 2 (5.1) 0 (0.0) 2 (10.0) 3 (5.7) 0 (0.0) 0 (0.0) 0 (0.0) 3 (6.7) 3 (15.8) 0 (0.0)
Hamstrings 26 (22.2) 1 (11.1) 2 (8.3) 7 (18.4) 16 (34.8) 14 (21.9) 3 (12.0) 1 (12.5) 2 (11.8) 11 (28.2) 3 (15.8) 8 (40.0) 12 (22.6) 0 (0.0) 0 (0.0) 0 (0.0) 12 (26.7) 4 (21.1) 8 (30.8)
Knee 14 (12.0) 2 (22.2) 6 (25.0) 6 (15.8) 0 (0.0) 10 (15.6) 7 (28.0) 2 (25.0) 5 (29.4) 3 (7.7) 3 (15.8) 0 (0.0) 4 (7.5) 1 (12.5) 0 (0.0) 1 (14.3) 3 (6.7) 3 (15.8) 0 (0.0)
Anterior lower leg 5 (4.3) 0 (0.0) 3 (12.5) 0 (0.0) 2 (4.3) 4 (6.3) 3 (12.0) 0 (0.0) 3 (17.6) 1 (2.6) 0 (0.0) 1 (5.0) 1 (1.9) 0 (0.0) 0 (0.0) 0 (0.0) 1 (2.2) 0 (0.0) 1 (3.8)
Posterior lower leg 16 (13.7) 2 (22.2) 3 (12.5) 3 (7.9) 8 (17.4) 5 (7.8) 3 (12.0) 2 (25.0) 1 (5.9) 2 (5.1) 0 (0.0) 2 (10.0) 11 (20.8) 2 (25.0) 0 (0.0) 2 (28.6) 9 (20.0) 3 (15.8) 6 (23.1)
Ankle (lateral) 2 (1.7) 0 (0.0) 0 (0.0) 2 (5.3) 0 (0.0) 1 (1.6) 0 (0.0) 0 (0.0) 0 (0.0) 1 (2.6) 1 (5.3) 0 (0.0) 1 (1.9) 0 (0.0) 0 (0.0) 0 (0.0) 1 (2.2) 1 (5.3) 0 (0.0)
Foot 12 (10.3) 1 (11.1) 6 (25.0) 1 (2.6) 4 (8.7) 7 (10.9) 6 (24.0) 1 (12.5) 5 (29.4) 1 (2.6) 1 (5.3) 0 (0.0) 5 (9.4) 1 (12.5) 0 (0.0) 1 (14.3) 4 (8.9) 0 (0.0) 4 (15.4)
TYPE
Concussion 1 (0.9) 0 (0.0) 0 (0.0) 1 (2.6) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (1.9) 0 (0.0) 0 (0.0) 0 (0.0) 1 (2.2) 1 (5.3) 0 (0.0)
Stress fracture 2 (1.7) 0 (0.0) 2 (8.3) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (3.8) 2 (25.0) 0 (0.0) 2 (28.6) 0 (0.0) 0 (0.0) 0 (0.0)
Other bone injuries 9 (7.7) 1 (11.1) 3 (12.5) 1 (2.6) 4 (8.7) 5 (7.8) 4 (16.0) 1 (12.5) 3 (17.6) 1 (2.6) 1 (5.3) 0 (0.0) 4 (7.5) 0 (0.0) 0 (0.0) 0 (0.0) 4 (8.9) 0 (0.0) 4 (15.4)
Ligmanetous injuries 9 (7.7) 0 (0.0) 1 (4.2) 7 (18.4) 1 (2.2) 5 (7.8) 1 (4.0) 0 (0.0) 1 (5.9) 4 (10.3) 3 (15.8) 1 (5.0) 4 (7.5) 0 (0.0) 0 (0.0) 0 (0.0) 4 (8.9) 4 (21.1) 0 (0.0)
Meniscus/cartilage 3 (2.6) 0 (0.0) 0 (0.0) 2 (5.3) 1 (2.2) 1 (1.6) 0 (0.0) 0 (0.0) 0 (0.0) 1 (2.6) 1 (5.3) 0 (0.0) 2 (3.8) 0 (0.0) 0 (0.0) 0 (0.0) 2 (4.4) 1 (5.3) 1 (3.8)
Muscle strain/tear 15 (12.8) 4 (44.4) 0 (0.0) 11 (28.9) 0 (0.0) 8 (12.5) 4 (16.0) 4 (50.0) 0 (0.0) 4 (10.3) 4 (21.1) 0 (0.0) 7 (13.2) 0 (0.0) 0 (0.0) 0 (0.0) 7 (15.6) 7 (36.8) 0 (0.0)
Muscle cramps 59 (50.4) 2 (22.2) 8 (33.3) 12 (31.6) 37 (80.4) 30 (46.9) 5 (20.0) 1 (12.5) 4 (23.5) 25 (64.1) 8 (42.1) 17 (85.0) 29 (54.7) 5 (62.5) 1 (100.0) 4 (57.1) 24 (53.3) 4 (21.1) 20 (76.9)
Tendinosis/tendinopathy/ aponeurosis 15 (12.8) 1 (11.1) 10 (41.7) 2 (5.3) 2 (4.3) 12 (18.8) 10 (40.0) 1 (12.5) 9 (52.9) 2 (5.1) 1 (5.3) 1 (5.0) 3 (5.7) 1 (12.5) 0 (0.0) 1 (14.3) 2 (4.4) 1 (5.3) 1 (3.8)
Arthritis/synovitis/bursitis/ impignement 4 (3.4) 1 (11.1) 0 (0.0) 2 (5.3) 1 (2.2) 3 (4.7) 1 (4.0) 1 (12.5) 0 (0.0) 2 (5.1) 1 (5.3) 1 (5.0) 1 (1.9) 0 (0.0) 0 (0.0) 0 (0.0) 1 (2.2) 1 (5.3) 0 (0.0)
SEVERITY
Minor 62 (53.0) 5 (55.6) 14 (58.3) 17 (44.7) 26 (56.5) 34 (53.1) 15 (60.0) 4 (50.0) 11 (64.7) 19 (48.7) 8 (42.1) 11 (55.0) 28 (52.8) 4 (50.0) 1 (100.0) 3 (42.9) 24 (53.3) 9 (47.4) 15 (57.7)
Moderate 36 (30.8) 1 (11.1) 6 (25.0) 12 (31.6) 17 (37.0) 21 (32.8) 6 (24.0) 1 (12.5) 5 (29.4) 15 (38.5) 8 (42.1) 7 (35.0) 15 (28.3) 1 (12.5) 0 (0.0) 1 (14.3) 14 (31.1) 4 (21.1) 10 (38.5)
Severe 19 (16.2) 3 (33.3) 4 (16.7) 9 (23.7) 3 (6.5) 9 (14.1) 4 (16.0) 3 (37.5) 1 (5.9) 5 (12.8) 3 (15.8) 2 (10.0) 10 (18.9) 3 (37.5) 0 (0.0) 3 (42.9) 7 (15.6) 6 (31.6) 1 (3.8)

For all athletes, there was a significant difference between acute and overuse injuries in the distribution of injury type (Chi2 = 40.9; p < 0.0001), but not for location and type.